Pharma: Other News To Note
Monday, August 20, 2012
Ranbaxy Pharmaceuticals Inc., of Princeton, N.J., said it launched an authorized generic version of pioglitazone hydrochloride tablets in the U.S. market, under an agreement with Takeda Pharmaceuticals Ltd., of Osaka, Japan.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.